Results: 1-12 |
Results: 12

Authors: DELANGE ECM DEBOCK G SCHINKEL AH DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., BBB TRANSPORT AND P-GLYCOPROTEIN FUNCTIONALITY USING MDR1A(- -) AND WILD-TYPE MICE - TOTAL BRAIN VERSUS MICRODIALYSIS CONCENTRATION PROFILES OF RHODAMINE-123/, Pharmaceutical research, 15(11), 1998, pp. 1657-1665

Authors: DESRAYAUD S DELANGE ECM LEMAIRE M BRUELISAUER A DEBOER AG BREIMER DD
Citation: S. Desrayaud et al., EFFECT OF THE MDR1A P-GLYCOPROTEIN GENE DISRUPTION ON THE TISSUE DISTRIBUTION OF SDZ-PSC-833, A MULTIDRUG RESISTANCE-REVERSING AGENT, IN MICE, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 438-443

Authors: MEIJER OC DELANGE ECM BREIMER DD DEBOER AG WORKEL JO DEKLOET ER
Citation: Oc. Meijer et al., PENETRATION OF DEXAMETHASONE INTO BRAIN GLUCOCORTICOID TARGETS IS ENHANCED IN MDR1A P-GLYCOPROTEIN KNOCKOUT MICE, Endocrinology, 139(4), 1998, pp. 1789-1793

Authors: DELANGE ECM DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., MONITORING IN-VIVO BLOOD-BRAIN-BARRIER DRUG TRANSPORT - CEREBROSPINAL-FLUID SAMPLING, THE UNIT IMPULSE-RESPONSE METHOD AND, WITH SPECIAL REFERENCE, INTRACEREBRAL MICRODIALYSIS, STP pharma sciences, 7(1), 1997, pp. 17-27

Authors: HAMMARLUNDUDENAES M PAALZOW LK DELANGE ECM
Citation: M. Hammarlundudenaes et al., DRUG EQUILIBRATION ACROSS THE BLOOD-BRAIN-BARRIER - PHARMACOKINETIC CONSIDERATIONS BASED ON THE MICRODIALYSIS METHOD, Pharmaceutical research, 14(2), 1997, pp. 128-134

Authors: DELANGE ECM DANHOF M DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., METHODOLOGICAL CONSIDERATIONS OF INTRACEREBRAL MICRODIALYSIS IN PHARMACOKINETIC STUDIES ON DRUG TRANSPORT ACROSS THE BLOOD-BRAIN-BARRIER, Brain research reviews, 25(1), 1997, pp. 27-49

Authors: DELANGE ECM DEVRIES JD ZURCHER C DANHOF M DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., THE USE OF INTRACEREBRAL MICRODIALYSIS FOR THE DETERMINATION OF PHARMACOKINETIC PROFILES OF ANTICANCER DRUGS IN TUMOR-BEARING RAT-BRAIN, Pharmaceutical research, 12(12), 1995, pp. 1924-1931

Authors: DELANGE ECM HESSELINK MB DANHOF M DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., THE USE OF INTRACEREBRAL MICRODIALYSIS TO DETERMINE CHANGES IN BLOOD-BRAIN-BARRIER TRANSPORT CHARACTERISTICS, Pharmaceutical research, 12(1), 1995, pp. 129-133

Authors: DELANGE ECM BOUW MR MANDEMA JW DANHOF M DEBEER AG BREIMER DD
Citation: Ecm. Delange et al., APPLICATION OF INTRACEREBRAL MICRODIALYSIS TO STUDY REGIONAL DISTRIBUTION KINETICS OF DRUGS IN RAT-BRAIN, British Journal of Pharmacology, 116(5), 1995, pp. 2538-2544

Authors: DELANGE ECM DANHOF M ZURCHER C DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., REPEATED MICRODIALYSIS PERFUSIONS - PERIPROBE TISSUE-REACTIONS AND BBB PERMEABILITY, Brain research, 702(1-2), 1995, pp. 261-265

Authors: DEBOER AG DEVRIES HE DELANGE ECM DANHOF M KUIPER J BREIMER DD
Citation: Ag. Deboer et al., DRUG TRANSPORT TO THE BRAIN - IN-VITRO VERSUS IN-VIVO APPROACHES, Journal of controlled release, 28(1-3), 1994, pp. 259-263

Authors: DELANGE ECM DANHOF M DEBOER AG BREIMER DD
Citation: Ecm. Delange et al., CRITICAL FACTORS OF INTRACEREBRAL MICRODIALYSIS AS A TECHNIQUE TO DETERMINED THE PHARMACOKINETICS OF DRUGS IN RAT-BRAIN, Brain research, 666(1), 1994, pp. 1-8
Risultati: 1-12 |